RNA-sequencing of human cervical cancer HeLa cells treated with splicing inhibitors Sudemycin C1, Sudemycin K, Spliceostatin A or control DMSO.. RNA-sequencing of human cervical cancer HeLa cells treated with splicing inhibitors Sudemycin C1, Sudemycin K, Spliceostatin A or control DMSO.

HeLa cells were co-treated with the drugs or DMSO control and BrU. After 3 hours, cells were harvested. Both total RNA and recently transcribed RNA (isolated by BrU immunoprecipitation) were sequenced.